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T helper (Th) cells are functionallyheterogenous (1-6), and in the murine system,
Mosmann et al. (4) have classified clones ofTh cells into two major subsets, termed
Thl and Th2. This classification is based, in part, on the pattern of lymphokines
that the two types ofTh clones secrete after mitogenic or antigenic stimulation. Thl
cells secrete IL-2 and IFN-y, whereas Th2 cells secrete IL-4 and IL-5 (4, 7). In ad-
dition, such clones differ in their ability to support a delayed-type hypersensitivity
reaction (5) and in the type ofhelp provided to B cells (4), includingthe differential
induction ofthe secretion of certain Ig isotypes (8). Similar subsets of rat Th cells
have been defined. Using a monoclonal anti-CD45 (lymphocyte-common antigen,
T-200), MRC-0X22, Arthur and Mason (9) have shown that MRC-0X22+ Th
cells produce IL-2, and MRC-0X22 - Th cells help B cells. More recently, anti-
bodies recognizing epitopes on the human (10) and murine (Birkcland, M. L., J.
Metlay, V. M. Sanders, R. Fernandez-Botran, E. S. Vitetta, R. M. Steinman, and
E. Pure, submitted for publication) CD45 family of molecules have been reported
to distinguish these two types of functionally different Th cells.
The mechanisms that control the preferential activation ofnormal analogs ofone
subset of Th cells vs. the other and the regulatory interactions between the two cell
types in vivo are not yet known. Work from our laboratory (11) and others (12, 13)
has demonstrated that clones of Thl and Th2 cells use IL-2 or IL-4, respectively,
as autocrine growth factors in vitro. In addition, Th2 cells can also use IL-2 as a
paracrine growth factor, and their responsiveness to IL-2 and IL-4 increases con-
comitantly after antigenic stimulation (14). These findings suggest that the prolifer-
ation of normal Th2 cells could be regulated, at least in part, by Thl cells. In the
present study, we have examined the effects that lymphokines produced by a clone
ofThl cells (IL-2 and IFN-y), by a clone ofTh2 cells (IL-4) or by APC (IL-1) have
on the antigen-induced proliferation of both clones.
Ourresults indicate that antigenic stimulation results in the acquisition ofrespon-
siveness by both types of clones to the proliferative effects of both IL-2 and IL-4.
This work was supported by National Institutes of Health grants AI-11851 and AI-12789. Address cor-
respondence to Ellen S. Vitetta, Dept. ofMicrobiology, University ofTexas Southwestern Medical Center
at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75235.
J. Exp. MED. © The Rockefeller University Press " 0022-1007/88/08/0543/16 $2.00
￿
543
Volume 168 August 1988 543-558544
￿
LYMPHOKINE REGULATION OF CLONES OF T HELPER CELLS
Responsiveness to both lymphokines decreases with time after initial activation, al-
though the Thl clone loses its responsiveness to IL-4 more rapidly and to IL-2 more
slowly than does the Th2 clone. Together, IL-2 and IL-4 induce a synergistic prolifer-
ative response in both types of Th clones. Both lymphokines must be present at the
same time in order for synergy to occur. Finally, in Th2 cells, IFN-y partially in-
hibits the proliferative responses induced by IL-4 and IL-2, whereas IL-1 synergizes
with IL-2 and IL-4. However, neither IFN-y nor IL-1 affect the IL-2- or IL-4-
mediated proliferation ofThl cells. Taken together, these data suggest that the antigen-
induced proliferation of a particular subset of Th cells may be partially modulated
by lymphokines produced by the other subset and that the pathways of IL-2- and
IL-4-mediated proliferation are related.
Materials and Methods
Animals.
￿
Female BALB/c mice, 7-10 wk of age, were purchased from Cumberland Farms
(Clinton, TN) or were bred in the animal facility ofthe Department ofMicrobiology, University
of Texas Southwestern Medical Center at Dallas.
Cell Lines.
￿
The IL-2/IL-4-responsive T cell line, HT-2 (15), was maintained in RPMI-
1640 medium containing 25 mM Hepes (Gibco Laboratories, Grand Island, NY), 10% heat-
activated FCS (Hyclone Laboratories, Logan, UT), penicillin (100 U/ml), streptomycin (100
4g/ml), gentamicin (10 wg/ml), L-glutamine (2 mM), 2-ME (50 wM), sodium pyruvate (1
mM), nonessential amino acids (0.1 mM), and human rIL-2 (10 U/ml) (rIL-2, AMGen, Thou-
sand Oaks, CA). The keyhole-limpet hemocyanin (KLH)-specific, I-Ad-restricted Th line,
T286 (11), was generated from the lymph nodes ofKLH-immunized BALB/c mice according
to the procedure described by Kimoto and Fathman (16). T286 cells were maintained by
a 4-5 day stimulation period in the presence of irradiated (3,300 rad) syngeneic spleen cells,
KLH (50 wg/ml), and supernatant (SN)t from Con A-stimulated rat spleen cells, fol-
lowed by a 7-14-d rest period. The T-286 cell is a Th2 cell as defined by its produc-
tion after antigenic or mitogenic stimulation of IL-4, but not IL-2 or IFN-y (11).
A second KLH-specific Th clone, HDK-1 (7), has been classified as a Thl cell based on its
production of IL-2 and IFN-y, but not IL-4, after antigenic or mitogenic stimulation (7).
The IFN-y-sensitive B lymphoma cell line, WEHI-279 (17) was kindly provided by Mr. Anwar
Michael (Department ofPathology, University of Texas Southwestern Medical Center at Dallas)
and was maintained in RPMI 1640 medium with 10% FCS and other supplements as de-
scribed for the culture of HT-2 cells, except for rIL-2 .
Antibodies, Lymphokines, andReagents.
￿
The monoclonal anti-IL-4 antibody, 11BIl (18), was
prepared by ammonium sulfate precipitation of hybridoma culture SNs. Affinity-purified
anti-IL-2 mAb, S4B6 (4) and anti-murine IFN-y, XMG1.2 (7) have been described. The
anti-IL-2-R antibody (7134) (19) was prepared by ammonium sulfate precipitation ofculture
SNs from the 7134 hybridoma (American Type Culture Collection, Rockville, MD). Rabbit
anti-human IL-1(i, which is crossreactive with mouse IL-1(i, was generously provided by Dr.
R. Newton (DuPont Glenolden Laboratory, Glenolden, PA). A polyclonal antibody (rabbit)
to IL-la was purchased from Cistron Technology (Pine Brook, NJ). A monoclonal directed
against natural human IL-1, which is crossreactive with murine IL-1, was purchased from
Genzyme (Boston, MA). IL-4 was purified from SNs of Con A-stimulated T286 cells ac-
cording to the method described by Ohara, et al. (20). IL-4 preparations lacked IL-2 and
IFN-y activities and their stimulatory effect on the proliferation of HT-2, T286, and HDK-1
cells could be completely inhibited by the monoclonal anti-IL-4 antibody, 111311. 1 U of IL-4
was defined as the reciprocal of the dilution of SN containing 50% of the maximal stimula-
tory activity of a standard IL-4 preparation in the HT-2 proliferation assay. Murine rIL-4
1 Abbreviations used in this paper: KLH, keyhole-limpet hemocyanin; p, maximal proliferation; SAC,
splenic adherent cells; SN, supernatant.FERNANDEZ-BOTRAN ET AL.
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and rIFN-y were prepared at DNAX (Palo Alto, CA); human rIL-2 was purchased from
AMGen (Thousand Oaks, CA), and human rIL-1a and a were obtained from Cistron Tech-
nology.
Lymphokine Assays.
￿
IL-2 and IL-4 activities were assayed by their ability to induce the
proliferation of HT-2 cells, as described (21) and by specific inhibition by anti-IL-2 or anti-
IL-4 antibodies, respectively. Briefly, HT-2 cells were plated in 96-well plates (5 x 103
cells/well) together with different dilutions of Th cell SNs in the presence and absence of
anti-IL-2 (S4B6) or anti-IL-4 (111311) antibodies. After 24 h of incubation at 37'C/7.50/0 C02,
['H]thymidine (1 gCi/well) was added, the plates were cultured for an additional 16 h, har-
vested, and counted. IFN-y was assayed by its ability to inhibit the proliferation of WEHI-
279 cells (17). In this assay, WEHI-279 cells were plated in 96-well plates at a density of 105
cells/ml with different dilutions of Th cell SNs or a standard rIFN-y preparation in the pres-
ence or absence of the anti-IFN-y antibody, XMG1.2 (7) . [3H]Thymidine (1 RCi/well) was
added after 24 h of incubation, and the cells were harvested and counted 16 h later.
Proliferation of Th Cells.
￿
Stimulation ofT286 (Th2) or HDK-1 (Thl) cells was accomplished
by culturing the Th cells (24-well plates) at a density of 5 x 105/ml in the presence of KLH
(50-100 ug/ml) and syngeneic splenic adherent cells (SAC) for 24 h at 37°C. The SAC were
prepared by removing the nonadherent cell fraction from culture wells previously seeded with
7 .5 x 106 irradiated spleen cells and incubated for 2 h at 37°C . After 24 h of stimulation,
the T cells were washed three times with balanced salt solution, 1% FCS, separated from
SAC and dead cells by centrifugation through Ficoll (Pharmacia Fine Chemicals, Uppsala,
Sweden), and subsequently cultured at a density of 106/ml in RPMI-1640-10% FCS medium
with no added lymphokines. Cells were harvested at different times during the secondary
culture, and their proliferative response to IL-2 or IL-4 in the presence or absence of other
lymphokines (IFN-y, IL-1) was measured using a 36-h proliferation assay. Briefly, T286 (Th2)
or HDK-1 (Thl) cells were harvested, washed two times in BSS-1% FCS, and incubated in
96-well plates at a density of 2 x 105 cells/ml in the presence of the indicated concentrations
of lymphokines. [3H]Thymidine (1 gCi/well) was added after 24 h of culture, and the cells
were incubated for an additional 16 h at 37'C. The cells were then harvested and counted.
[3H]Thymidine incorporation was taken as a measure of proliferation.
Staining.
￿
Cells were stained for IL-2-R after the indicated times of culture. Briefly, the
cells were incubated for 30 min at 4°C with biotinylated (B) anti-IL-2R (7134) antibodies
in PBS-azide (10 mM)-1% FCS, followed by three washes. Cells were incubated with FITC-
avidin (Vector Laboratories, Burlingame, CA), counterstained with propidium iodide (5 wg/ml)
(in order to exclude dead cells), and were analyzed on the FAGS.
Results
Thl and Th2 Clones.
￿
Two clones of similar antigenic specificity (KLH) and MHC
restriction (IAd), but belonging to different Th subtypes, were chosen for compar-
ison. HDK-1 and T-286 clones have been classified as Thl and Th2 subtypes, respec-
tively, based on their pattern of lymphokine secretion after antigenic or mitogenic
stimulation (4, 7). Thl cells secrete IL-2 and IFN-y, whereas Th2 cells secrete IL-4
(7, 11) . Table I shows the lymphokine levels secreted after antigenic stimulation, as
detected by biological assays and inhibitionwith monoclonal anti-lymphokine anti-
bodies. Results have also been confirmed by hybridization ofcytoplasmic RNA with
lymphokine-specific cDNA probes (7, 11). Both clones are able to provide antigen-
specific, MHC-restricted help to B cells under conditions ofcognate interaction (8).
Responsiveness of Thl and Th2 Cells to IL-2 and IL-4 after Antigenic Stimulation.
￿
In
previous experiments, we have observed that after antigenic stimulation, Th2 cells
secrete IL-4 and proliferate in response to both IL-4 and IL-2 (11, 14). Although
Thl cells would be expected to acquire responsiveness to IL-2 in a similar manner,
it was not clear whether Thl cells would respond to IL-4 after antigenic stimulation.546
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TABLE I
Lymphokines Secreted by Two Types of Th Cell Clones
after Antigenic Stimulation
Activity (U/ml)
Cell lines
￿
IL-2
￿
IL-4
￿
IFN-y
HDK-1 (Th,)
￿
25
￿
<0 .1
￿
23 .5
T-286 (Th2)
￿
<0 .1
￿
37 .5
￿
<0.01
Culture SN from antigen-stimulated HDK-1 and T-286 cells were collected af-
ter a 24-h incubation of the T cells (T) at a density of 5 x 10 5 cells/ml with
KLH (50 lag/ml) and irradiated (3,300 rad) SAC from BALB/c mice . After filtra-
tion (0.22 w), the T cell SNs were tested for the presence of IL-2, IL-4, and
IFN-y, as described in Materials and Methods . Results are from a representa-
tive experiment.
We thus compared the responsiveness ofThl andTh2 cells with both IL-2 and IL-4
at various times after antigenic stimulation . In addition, we examined the main-
tenance of responsiveness as a function of the time in culture after removal of both
the antigen and the secreted lymphokines .
Asshown in Fig. 1, antigenic stimulation resulted in the acquisition of responsive-
ness by the two types ofTh clones to both IL-2 (Fig. 1 A and C) and IL-4 (B and
D), although the maximal level of proliferation attained at optimal doses of IL-4
was always lower than that observed with IL-2 . The absolute degree of proliferation
([3H]Thymidine incorporation ; cpm/culture) to IL-4 at day 1 after stimulation was
similar for both types of clones ; however, when the maximal proliferation with IL-4
(pIL-4) was expressed as a fraction of the maximal proliferation with IL-2 (pIL-2),
Th1 cells were relatively less responsive to IL-4 (pIL-4/pIL-2 = 0.23) than Th2 cells
(pIL-4/pIL-2 = 0.43) . In the absence of additional stimuli, responsiveness to both
A
IL-2
FIGURE 1 .
￿
Responsiveness ofThl
(HDK-1) (A and B) and Th2 (T-286)
(C and D) clones to IL-2 (A and C)
and IL-4 (B and D) as a function of
time elapsed after antigenic stimu-
lation . Thl or Th2 cellswere stimu-
lated with antigen (KLH, 50 gg/ml)
in the presence ofirradiated SAC for
24 h . The Th cells were harvested,
washed, and recultured in the pres-
ence ofaddedlymphokines . Respon-
siveness of the Th cells to different
doses of IL-2 and IL-4 was tested
by a proliferation assay at 1 (0),
2 (O), 5 (A), and 8 d (/) after an-
tigenic stimulation . The figure de-
picts the results of a representative
experiment of four performed .
Points represent the mean oftripli-
cate wells. The proliferative re-
sponses of T286 and HDK-1 cells
to the IL-4 preparation could be
completely inhibited by the mono-
clonal anti-IL-4 antibody, 11BIl
Lymphokine concentration (U/ml)
￿
(18), but not by the monoclonal
anti-IL-2 antibody, S4B6 (4) .
e
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TABLE II
The Proliferation of Th1 Cells to IL-4 Is not Dependent on IL-2
HDK-1 cells (Thl) were stimulated with KLH (50 gg/ml) and SAC . 2 d later,
the Th cells were harvested and tested for their ability to proliferate to IL-2 or
IL-4 in the presence and absence of anti-IL-2 (S4136, 2 lig/ml) or anti-IL-4 (111311,
2 ltg/ml). Results represent the mean of triplicate experiments t SEM .
lymphokines decreased with time after initial antigenic stimulation, although Thl
cells lost their responsiveness to IL-4 more rapidly and to IL-2 more slowly than
Th2 cells. In fact, after 4 d of culture, Thl cells were no longer responsive to IL-4,
but retained their responsiveness to IL-2. In contrast, in concomitant assays, Th2
cells showed a parallel decrease in their responsiveness to both lymphokines. After
the same stimulation and culture protocol, analysis of the expression of IL-2-Rs by
indirect immunofluorescence with the anti-IL-2R antibody, 7134 (19), demonstrated
that the levels of expression of IL-2R, as measured by the mean fluorescence inten-
sity, followed a similarcourse to that described for IL-2 responsiveness. IL-2-R levels
increased as a result of antigenic stimulation and then gradually returned to base-
line levels (results not shown).
The IL-4-mediated Proliferation of Th1 Cells Is not Mediated by Endogenously-produced
IL-2. Although it is clear that HT 2 and Th2 cells respond to IL-4 and IL-2 in-
dependently (11, 21), the possibility existed that the proliferation of Thl cells ob-
served in the presence of IL-4 was the result of endogenous production and utiliza-
tion of IL-2 as a consequence of IL-4 stimulation. To determine whether this was
the case, Thl cells were harvested 1-2 d after initial activation and assayed for their
ability to proliferate in response to IL-4 in the presence of anti-IL-2 or anti-IL-4
antibodies. As shown in Table II, the presence of anti-IL-2 antibodies at concentra-
tions that completely inhibited IL-2-mediated proliferationhad no effect on the IL-
4-mediated proliferation of the Thl cells, while the anti-IL-4 antibodies completely
inhibited such responses. These results suggest that the IL-4-mediatedproliferation
of Thl cells cannot be attributed to the endogenous production of IL-2, unless IL-2
can deliver a signal to the receptor inside the cell before exposure to the antibody.
Effects ofIFN-y on Thl and Th2 Proliferation.
￿
Although IFN-y is known to inhibit
the effects of IL-4 on B cells (17, 22-26), no effects on the IL-4-mediated prolifera-
tion of Th cells have been reported. In this regard, the ability of Thl and Th2 cells
to proliferate in response to IL-2 or IL-4 wasmeasured in the presence ofincreasing
concentrations of rIFN-y (1-50 U/ml). As shown in Fig. 2 (A and B), rIFN-y had
Lymphokine added
Antibody
Anti-IL-2
added
Anti-IL-4
[3H]Thymidine
incorporation
cpm1culture
None - - 1,411 t 465
None + - 1,370 t 184
None - + 1,814 t 199
IL-2 (1 U/ml) - - 91,086 t 907
IL-2 + - 1,170 ± 71
IL-2 - + 83,739 t 2,000
IL-4 (25 U/ml) - - 11,255 ± 720
IL-4 + - 10,519 ± 47
IL-4 - + 1,007 ± 112548
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FIGURE 2 .
￿
Effect ofmurine rIFN-y
on the proliferation ofThl (HDK-1)
(A and B) or TH2 (T-286) (C and
D) cells to IL-2 (A and C) and IL-4
(B and D) . Th cells were stimulated
with antigen and irradiated SAC as
described . After2-5 d ofculture in
the absence of antigen or lym-
phokines, proliferation of the Th
cells to IL-2 or IL-4 was measured
in the presence of rIFN-y at the
final concentrations of0 (" ), 1 (O),
10 (A), and 50 U/ml (0) . Results
represent the mean oftriplicate ex-
periments.
little effect, if any, on the IL-2- or IL-4-mediated proliferation ofThl cells . In con-
trast, rIFN-y partially inhibited (30-60%) both the IL-2- and IL-4-mediated prolifer-
ation ofTh2 cells (Fig. 2, C and D) . The inhibition of proliferation observed with
rIFN-y was never complete even at higher concentrations . Furthermore, the fact that
different concentrations ofrIFN-y did notcause a significant shift in thedose-response
curves to IL-2 or IL-4, but did cause a change in the level of proliferation, suggests
that rIFN-y acts asanoncompetitive antagonist in theIL-2- or IL-4-mediated prolifer-
ation of Th2 cells . Th2 cells harvested at different times after stimulation showed
IL-4
6 e
￿
1 z s
Days after antigenic stimulation
FIGURE 3 .
￿
Effect of rIL-1 on the
proliferation of Thl (A and B) and
Th2 (C and D) cells to IL-2 (A and
C) and IL-4 (B and D) as a function
of the time elapsed after antigenic
stimulation . Th cells were stimu-
lated and cultured as described. Pro-
liferation to 5 (" , O) and 0.5 U/ml
(A, A) of IL-2 or 25 (" , O) and
10 U/ml (A, A) IL-4 was tested in
the presence (O, A) or absence (" ,
A) of human rIL-ID at 10 U/ml at
different times after antigenic stim-
ulation . Results represent the mean
of triplicate experiments .FERNANDEZ-BOTRAN ET AL.
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TABLE III
The Effect ofAnti-IL-1 Antibodies on the Proliferation
of Th2 Cells to IL-2 or IL-4
T-286 (Th2) cells were stimulated and cultured as described. 2-3 d after culture
in the absence of antigen, the cells were harvested and tested for their ability
to proliferate to IL-2 or IL-4 in the presence and absence of rIL-1[I and/or anti-
IL-la/p antibody. Results represent the mean of triplicate experiments * SEM.
similar degrees of inhibition by IFN-y, suggesting that responsiveness to this lym-
phokine did not follow the same time course as responsiveness to IL-2 or IL-4.
Effects ofIL-1 on the Proliferation of Thl and Th2 Clones. The requirement for IL-1
in the responses of Th cells to antigens (27-29) and, more recently, to IL-4 hasbeen
reported by several groups (13, 30, 31). This prompted us to investigate the effects
of IL-1 on the proliferation of Thl and Th2 cells after antigenic stimulation and
to determine whether IL-1 was required for IL-4-mediated proliferation. rIL-la or
rIL-1Q alone did not show any proliferative activity at doses up to 10 U/ml. How-
ever, both forms of IL-1 synergized with IL-2 or IL-4 in the proliferation of Th2
cells. In contrast, rIL-1 (a or R) had very little effect on the proliferation of Thl cells.
Fig. 3 (A-D) shows the effects of IL-1 on the proliferative response of Thl and Th2
cells to IL-2 and IL-4. Interestingly, the enhancement ofproliferation was most evi-
dent when the cells were harvested 2 d after antigenic stimulation.
The addition of anti-IL-1 antibodies at doses that completely inhibited IL-1 ac-
tivity (a anda) (10 U/ml) in a thymocyte proliferation assay (32), had no effect on
theproliferation of HDK-1 or T-286 cellsto IL-4. In fact, even when such antibodies
inhibited the synergy between IL-1 and IL-4 on T-286 cells, they were unable to
inhibit proliferation beyond that attained with IL-4 alone (Table III). These results
suggest that although IL-1 is able to synergize with IL-4, IL-1 is not an absolute
requirement for the proliferation of some Th2 clones.
Synergy between IL-2andIL-4.
￿
Since both Thl and Th2 cells are able to proliferate
in response to IL-2 and IL-4 shortly after antigenic stimulation, we next investigated
the effects of a mixture of IL-2 and IL-4 on the proliferation of both Thl and Th2
cells. As shown in Fig. 4 (A and B), both HDK-1 and T286 cells responded in a
synergistic fashion to the simultaneous addition of IL-2 and IL-4. Furthermore,
in accord with the greater sensitivity of Th2 cells to IL-4, T286 cells were able to
synergize in a more efficient manner (4.2-fold) than HDK-1 cells (2.7-fold). When
Lymphokine Anti-IL-1
[3H]Thymidine
incorporation
cpm/culture
None - 1,104 + 105
IL-2(1 U/ml) - 59,326 ± 3,989
IL-4 (10 U/ml) - 22,836 ± 1,534
IL-2 + 56,303 ± 2,375
IL-4 + 20,910 ± 677
IL-1 (5 U/ml) - 1,202 t 122
IL-2 + IL-1 - 101,125 t 4,353
IL-4 + IL-1 - 40,757 ± 2,965
11-2 + IL-1 + 55,401 ± 2,375
IL-4 + IL-1 + 21,337 t 1,625550
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increasing doses of IL-2 were titnated against increasing doses of IL-4 (Fig. 5, A
and B), it was evident that neither lymphokine changed the concentration of the
other which was required to elicit a half-maximal level of proliferation, but rather
increased the maximal level of proliferation. These results suggest that IL-2 andIL-
4 do notsynergizeby increasing the affinity of their respective receptors. The syner-
gistic effects of IL-2 and IL-4 were demonstrated with both recombinant andpurified
IL-4 (results not shown) . The synergy between the two lymphokines was more evi-
dent 4-5 d after antigenic stimulation when responsiveness to either lymphokine
alone had decreased considerably.
Kinetics of the Synergy between IL-2 and IL-4.: DelayedAddition.
￿
In B cells, IL-4 acts
before a secondary stimulus, such as anti-Ig or LPS, to induce B cell proliferation
(33-35) or IgGi secretion (35, 36), respectively. We thus determined whether IL-4
could act before IL-2 (or vice versa) at inducing a synergistic proliferative response
in Th cells. In theseexperiments, we studiedthe synergistic response of Th2 (T-286)
cells because of their higher response to IL-4. Th2 cells were harvested 4-5 d after
activation (when cells are no longer proliferating) and were cultured in microtiter
wells with medium aloneor with either IL-2 or IL-4 at concentrations giving similar
proliferative responses (time 0). At different times, IL-2 and IL-4 were added to
wells containing medium alone, IL-4 was added to wells containing IL-2, and IL-2
was added to wells containing IL-4. Thecellswere then cultured for36 handprolifer-
ation was measured . As shown in Figure 6, synergistic responses (when compared
with cells cultured with IL-2 or IL-4 only) were observed irrespectively of which
lymphokine was added first. Cells cultured with either IL-2 or IL-4 during the first
phase of the culture gave abetter proliferative response than those receiving medium
alone, suggesting that the presence of either lymphokine was required to maintain
c
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THz FIGURE 4.
￿
IL-2 andIL-4 synergize to
induce the proliferation of Thl (A) or
Th2 (B)cells. Th cells were stimulated
andcultured as described. 4-5 dafter
antigenic stimulation, their prolifera-
tion to medium alone (0) or to IL-2
(1 U/ml)(O)wasmeasured in thepres-
ence ofincreasingconcentrations ofIL-
4. After36 h, the cells were pulsed with
1 pCi/well of [3H]thymidine and har-
vested 12 hlater. Results represent the
mean of triplicate experiments.
FIGURE 5.
￿
SynergybetweenIL-2 and
IL-4. Thl (A)or Th2(B)cells were har-
vested 2-5 d after stimulation and in-
creasing doses of IL-2 were titrated
against increasing doses of IL-4 in a
36-h proliferation assay. IL-2 concen-
trations were 0 ("), 0.5 (/), 1 ("),
and 10 U/ml (O). Resultsrepresentthe
mean of triplicate experiments.0
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initially with IL-2 (group B) received IL-4
IL-2 (El) (phase II). After 36 h in culture,
harvested 12 h later,
synergy. Although the degree of proliferation decreased by delaying the addition
of the second lymphokine, when compared with cells cultured with only one lym-
phokine, a synergistic effect was observed throughout the experiment.
Kinetics of the Synergy between IL-2 and IL-4: Wash-out Experiment.
￿
To investigate
whether the signal provided by the first lymphokine could be separated from the
signal provided by the second, T286 cellswere cultured as described for the delayed
addition experiment, except that the first lymphokine was washed out before the
second lymphokine was added. In control cultures, cells were incubated in the ab-
sence oflymphokines during the first phase of culture and with both or either lym-
phokine during the second phase of culture. As shown in Fig. 7, and in contrast
to the previous experiment, synergywas observed only when both lymphokineswere
provided simultaneously. If the first lymphokine was removed before the addition
ofthe second, synergy was not observed andproliferation was comparable with that
attained in the presence ofthe second lymphokine alone. These results suggest that
in order for IL-2 and IL-4 to synergize, both must be present at the same time.
Discussion
In the present report, we have compared the IL-2- and IL-4-mediated responses
of two KLH-specific, I-Ad-restricted Th clones, one of the Thl type, and the other
of the Th2 type. We have also studied the effects of IFN-y and IL-1 on the IL-2-
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FIGURE 6.
￿
Kinetics of IL-2/IL-4 synergy in a
delayed-addition experiment. T-286 (Th2) cells
were stimulated with antigen (KLH, 50 ug/ml),
cultured as described, and harvestedafter 5 din
culture. Afterharvestandremovalofantigen, the
cells were divided into three groups (A, B, and
C) andincubatedforatotalof 36 h usingatwo-
phase culture. At the initiation of phase I (time
0), groupAwascultured with medium alone(0,
A, /), group B with IL-2 (1 U/ml) (A), and
group C with IL-4 (10 U/ml) (0). At different
timesafterinitiation ofphaseI (x-axis), cells that
were cultured with medium alone (group A) re-
ceived amixture of IL-2 andIL-4 (*); IL-2 alone
(A); or IL-4 alone (/). Control cells cultured
(A)andcellscultured initially with IL-4 group C) received
thecells were pulsed with 1 pCi/well of [ H]thymidine and
FIGURE 7.
￿
Kinetics of IL-2/IL-4 synergy in a
'wash-out" experiment. Th2 cellswere cultured
as described in Fig. 6, except that the firstlym-
phokine was removed by washing (three times)
before theaddition of the second lymphokine(s)
(phase II).552
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and IL-4-mediated responses. Our major findings are as follows. (a) Both types of
Th cells proliferate in response to either IL-2 or IL-4 after antigenic stimulation.
However, Th2 cells were more responsive to the effects of IL-4. (b) Responsiveness
to IL-2 and IL-4 decreases rapidly in both Th subsets as a function of time after
activation. (c) IL-2 and IL-4 synergize in inducing proliferation of both activated
Th clones but synergy requires the simultaneous presence of both lymphokines. (d)
In contrast to Th2 cells, Thl cells were not susceptible to either the inhibitory effects
of IFN-y or the synergistic effects between IL-1 and either IL-2 or IL-4.
Secretion of lymphokinesby both Th subsets is not constitutive, but is dependent
on mitogenic or antigenic stimulation (4, 7, 11). Moreover, when harvested at the
endoftheirnormal rest period (7-14 d), cells areunresponsive to the growth-promoting
effects of IL-2 or IL-4, indicating that activation through the TCR induces lym-
phokine secretion and responsiveness. This responsiveness is probably mediated by
the up-regulation of membrane receptors for IL-2 and IL-4. In vivo, such prolifera-
tion should be self limited, allowing for the controlled expansion of the activated
Th cells. Indeed, after activation in vitro, lymphokine release is complete by 24-48 h
(37), and our results have shown a progressive decrease in responsiveness to both
IL-2 and IL-4 associated with a down-regulation in the density of IL-2-R.
The relationship between the two types ofTh cell subsets in vivo is notyet under-
stood. It is unclear whether the two subsets represent different lineages or different
stages of the same lineage. In either case, in vivo immunization would probably lead
to the activation of antigen-specific Th cells from both subsets, even though the
precursor frequencies might differ depending on the antigen used. The fact that
Th2 cells up-regulate IL-2-R and proliferate in response to IL-2 to a greaterdegree
than to IL-4, suggests that in order foran optimal response to occur, Thl cells would
also have to be activated. Based on our results, we would predict that shortly after
antigenic stimulation, IL-2 and IL-4 produced by Thl and Th2 cells, respectively,
would not only be used by both autocrine and paracrine mechanisms, but that their
combined effects would be synergistic, especially when the responsiveness of both
subsets decreases and less than optimal levels of lymphokines are available. On the
otherhand, IFN-yproduction by Thl cells would regulate Th2 cell function by down-
regulating proliferation and would also inhibittheeffects of IL-4 on Bcells(17, 22-26).
Ourresults are in agreementwith those ofKurtJones et a1. (31) whodemonstrated
that Th2 cells respond more effectively to IL-4 than do Thl cells. In contrast to our
results, however, their Thl clones did not respond to IL-4 at all. This discrepancy
can be explained by the fact that they assayed the responsiveness of their clones to
IL-4 after8 d of culture. Thus, ourThl cells, although responsive to IL-4 soon after
antigenic stimulation, lose their responsiveness to IL-4 rapidly, becoming unrespon-
sive after 4 d, while still retaining responsiveness to IL-2 .
The decrease in the responsiveness of Thl and Th2 cells to IL-2 correlates with
aconcomitant decrease in the levels of IL-2-Rs. However, the antibody used to de-
tect IL-2-R reacts with both high- and low-affinity IL-2-R (p55 subunit) (38) and,
as such, a precise estimation of the number ofbiologically relevant high-affinity IL-
2-R (39) that are responsible for the proliferative response, cannot be made. The
responsiveness of Thl and Th2 cells to IL-4 is probably related to their expression
of IL-4-Rs. Along these lines, Ohara and Paul (40) have reported an increase inFERNANDEZ-BOTRAN ET AL.
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the number of IL-4-R on splenic T cells after mitogenic stimulation, and KurtJones
et al. (31) have reported a relatively higher number of IL-4-R on Th2 cells than
on Thl cells. In light of the differences in IL-2- and IL-4-responsiveness between
Thl and Th2 cells, one could speculate that differences also exist in the manner
in which these two Th subsets regulate their receptors for IL-2 and IL-4.
The antagonistic effects of IFN-y on the IL-4-mediated activities on B cells are
well-documented (17, 22-27, 41). With regard to Th2 cells, the partial inhibitory
effect of IFN-y was not restricted to IL-4-, but also to IL-2-mediated proliferation,
suggesting that, at least in T cells, IFN-y does not act by inhibiting only IL-4-
mediated signals. Indeed, SnapperandPaul (41) have reported that in LPS-stimulated
B cells, the effects of IFN-y are independent ofthose ofIL-4. The inhibition of IFN-y
on the IL-2- and IL-4-mediated proliferation ofTh2 cellswasonly partial (30-60%)
and could not be increased by increasing the levels of IFN-y. Similarly, Oliver et
al. (26) have also found partial inhibitory effects of IFN-y on the IL-4-mediated in-
crease in Ia antigens on B cells. The reasons for the partial inhibition are unclear
at present. A possibility for the decreased proliferation of Th2 cells in the presence
of IFN-y could be the result of a toxic effect of IFN-y on these cells. However, the
fact that the inhibitory effects of IFN-y were more evident at high concentrations
of IL-2 or IL-4 rather than at low concentrations, suggests that IFN-y might inter-
fere with cell proliferation rather than cell viability. In contrast to Th2 cells, IFN-y
was unable to inhibit IL-4- or IL-2-mediated proliferation of Thl cells, suggesting
that the latter cells maylack or have lower numbers of IFN-y receptors, or that their
growth machinery is not susceptible to inhibition by IFN-y.
IL-1 has been reported to be a cofactor required for the responses of certain Th
cells to antigenic stimulation (27-29). More recently, several Th2 cells such as D.10G4
(42) and CDC25 (43) have also been reported to require the presence of IL-1 in
order to respond to IL-4 (13, 31). In our initial experiments, however, we observed
significant proliferation of our Thl or Th2 cells in the absence of added IL-1. The
possibility exists, however, that contaminating macrophages from theAPC cellsused
during stimulation, provide a source of IL-1. Arguing against this, the addition of
anti-IL-1 antibodies at concentrations that inhibited IL-1 activity (a and R) in a
thymocyte proliferation assay were unable to affect the response of Thl or Th2 cells
to IL-4, suggesting that not all Th2 cells require IL-1 in order to respond to IL-4 .
Nevertheless, although the failure of anti-IL-1 antibodies to inhibitthe IL-4-mediated
proliferation of Th2 cells would argue against the need for soluble IL-1, we cannot
rule out a potential role for membrane-bound IL-1 in IL-4-mediated proliferation
of Th cells. An alternative explanation is that shortly after activation, Th2 cells are
able to respondto IL-4 alone, but as they lose their responsiveness to this lymphokine,
IL-1 can act as cofactor enabling them to respond to IL-4. In fact, Kupper et al .
(13) reported that antigen-stimulated D.10G4 cells are able to respond to IL-4 in
the absence of IL-1 shortly after stimulation. Manger et al. (44) have also reported
that activatedhuman T cells do not requireIL-1 forinduction of proliferation (after
anti-CD3 stimulation) while restingT cells do require IL-1. Moreover, the addition
of IL-1 to the T-286 cells, even when not absolutely required, had synergistic effects
on the IL-2- and IL-4-mediated proliferation, indicating that IL-1 can potentiate
the effects of IL-4 (and IL-2). Such synergistic effects have also been observed in554
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D.10G4 cells (13) . In contrast to Th2 cells, IL-1 had little or no effect on the IL-2-
or IL-4-mediated proliferation ofThl cells. Such resultsare in agreement with those
of KurtJones et al. (31), who also reported that Th2, but not Thl, cells are respon-
sive to IL-1, and suggested that Th2 cells express higher numbers of high-affinity
IL-1-R.
From a functional point of view, the synergy between IL-2 and IL-4 could pro-
vide a mechanism for acooperativeresponse between the two Th cell subtypes. From
abiochemical perspective, it suggests that the pathways of IL-2- and IL-4-mediated
proliferation areinterrelated. Results from wash-out experimentsindicate that IL-2
and IL-4 must be present simultaneously in orderforsynergyto occur. It is possible
that synergy requires simultaneous signalling through both IL-2-R and IL-4-R, ei-
ther independently ofeach otheror through some type ofreceptor/receptorinterac-
tion. Indeed, hormone-induced receptor interactions, as manifested by changes in
the affinity or number of receptors for a second hormone, are often accompanied
by synergybetween thetwo hormones or by imitation of the effects of one hormone
by the other (reviewed in reference 45). Along these lines, Walker et al. (46) have
demonstrated ahierarchical patternof receptor interactions, as evidencedby receptor
down-regulation, among receptors for several hemopoietic growth factors, including
IL-3, granulocyte-monocyte colony stimulatingfactor (GM-CSF), granulocyte-CSF
(G-CSF) and monocyte-CSF (M-CSF). We have obtained evidence for an IL-4-
mediated down-regulation of IL-2-Rs, suggesting a potential IL-4-R/IL-2-R inter-
action (Fernandez-Botran, R., V. M. Sanders, and E. S. Vitetta, manuscript in
preparation). There are, therefore, several mechanisms that could operate in vivo
to amplify initial stimulation of both Th subsets and, subsequently, turn-off their
responses. A hypothetical scenario would be that antigenic stimulation in the con-
text of cognate interaction induceslymphokine secretion (IL-2, IL-4, and IL-1) and
upregulation in the number of IL-2-R and IL-4-R, resulting in the acquisition of
responsiveness to the secreted lymphokines and leading to increased proliferation
of both Th subsets (to IL-2 and IL-4 as a result of synergy amongst the three lym-
phokines). IFN-Y would act by regulating both Th2 proliferation and the effects of
IL-4 on B cells. Antigen depletionwould then result in cessationoflymphokine secre-
tion and decreased responsiveness due to a reduction in the number of IL-2 and
IL-4 receptors. These effects wouldresult in a return ofthe T cellsto anon-dividing
state.
In addition to the reported effects of IL-2, IL-4, IFN-'Y, and IL-1 on the prolifera-
tion of Th1 and Th2 cells, such lymphokines might also affect another aspect of
Th cell function, such as lymphokine secretion. The possibility is currently being
investigated. Moreover, regulation at the level of the Th cells will eventually lead
to regulation at the level of B cell activation and differentiation. Indeed, both Th
clones used in these studies are able to provide help to B cells (4) and induce the
secretion of different IgG isotypes. (8).
Interpretation of the data reported here could be more complicated if there is
additional heterogeneity among Th cell subtypes or differences between cloned Th
cellsand normal Th cells (6). Recently, different laboratories have reported theexis-
tence in human (9) and mouse (10) of cell surface markers which may distinguish
Th cell subsets based on reactivity with antibodies recognizing certain epitopes onFERNANDEZ-BOTRAN ET AL.
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the CD45 surface molecules (lymphocyte common antigen, T-200). The use of such
reagents should facilitate studies of how Th cell subsets are regulated in vivo.
Summary
Murine Thl and Th2 subsets differ not only in the lymphokines they produce,
but also functionally. It is not clear what factors influence the preferential activation
of one subset versus the other and what regulatory interactions exist between them .
The purpose of this study was to examine the effect of lymphokines produced by
clones of Thl cells (IL-2 and IFN-y), Th2 cells (IL-4), and APC (IL-1) on the prolifer-
ative response of Thl and Th2 cells after antigenic stimulation. Activation of both
types of clones in the presence of antigen and APC resulted in the acquisition of
responsiveness to the proliferative effects of both IL-2 and IL-4, although Th2 cells
were more responsive to IL-4 than Thl cells. Reponsiveness of Thl and Th2 cells
to both lymphokines decreased with time after initial antigenic activation; Thl cells
lost their responsiveness to IL-4 more rapidly and to IL-2 more slowly than Th2
cells. IFN-y partially inhibited the IL-2- and IL-4-mediated proliferation of Th2,
but not Thl cells. Although the presence of IL-1 was not required for the response
of Thl or Th2 cells to IL-4, its presence resulted in a synergistic effect with IL-2
or IL-4 in Th2 but not in Thl cells. Both subsets responded to a mixture of IL-2
and IL-4 in synergistic fashion. Delayed addition and wash-out experiments indi-
cated that both IL-2 and IL-4 had to be present simultaneously in order for synergy
to occur. These results suggest that Th cell subsets might regulate each other via
the lymphokines that they secrete and that the pathways of IL-2- and IL-4-mediated
proliferation are interrelated.
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Noteaddedinproof Recent studies by Gajewski and Fitch (47) have shown that the IL-1-dependent
response of Th2, but not Thl, clones is suppressed by IFN-y . These results agree with our
finding that IFN-y acts on Th2, but not Thl, cells.
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